Literature DB >> 19085127

Developments in macromolecular drug delivery.

Mattias Belting1, Anders Wittrup.   

Abstract

Macromolecular drugs hold great promise as novel therapeutics of several major disorders, such as cancer and cardiovascular disease. However, their use is limited by lack of efficient, safe, and specific delivery strategies. Successful development of such strategies requires interdisciplinary collaborations involving researchers with expertise on, e.g., polymer chemistry, cell biology, nanotechnology, systems biology, advanced imaging methods, and clinical medicine. This not only poses obvious challenges to the scientific community but also provides opportunities for the unexpected at the interface between different disciplines. This introductory chapter summarizes and gives references to studies on macromolecular delivery that should be of interest to a broad scientific audience involved in macromolecular drug synthesis as well as in vitro and in vivo drug delivery studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19085127     DOI: 10.1007/978-1-59745-429-2_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Pharmacological modulation of cytotoxicity and cellular uptake of anti-cancer drugs by PDE5 inhibitors in lung cancer cells.

Authors:  Qing Li; Yan Shu
Journal:  Pharm Res       Date:  2013-07-25       Impact factor: 4.200

2.  Antigen shedding may improve efficiencies for delivery of antibody-based anticancer agents in solid tumors.

Authors:  Youngshang Pak; Yujian Zhang; Ira Pastan; Byungkook Lee
Journal:  Cancer Res       Date:  2012-05-04       Impact factor: 12.701

Review 3.  The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumors.

Authors:  Tünde Szatmári; Katalin Dobra
Journal:  Front Oncol       Date:  2013-12-19       Impact factor: 6.244

4.  TAT-mediated transduction of bacterial redox proteins generates a cytoprotective effect on neuronal cells.

Authors:  Cecilia L Balaban; Claudia Banchio; Eduardo A Ceccarelli
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.